Botulinum Toxin Injections for Thoracic Outlet Syndrome
Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Botulinum toxin type A injected into the anterior and middle scalene muscles will reduce the
irritation on the neurovascular structures at the interscalene triangle in subjects with TOS.
This will lead to reductions in pain and paresthesias, and improvements in function when
compared with injection of placebo.
Phase:
Phase 1
Details
Lead Sponsor:
University of British Columbia
Collaborator:
Merz Pharmaceuticals
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA